Novo Nordisk's pricing methods inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of selling price gouging, mentioning the stark distinction involving U.S. prices and people in Europe and copyright. Particulars: The two Rybelsus and